Artificial intelligence (AI) is emerging as a technology that can solve longstanding problems in drug development, including drug discovery. This report highlights the key machine learning and deep learning technologies (architectures and algorithms), companies, and applications driving billion-dollar investments and deals between the biopharma industry and AI drug discovery start-ups. AI will significantly accelerate drug discovery timelines and introduce substantial cost savings for the biopharma industry.